KUMEL Repository
1. Journal Papers (연구논문)
1. School of Medicine (의과대학)
Dept. of Internal Medicine (내과학)
Sunitinib 치료 이후 발생한 갑상선중독증 1예
- Keimyung Author(s)
- Kim, Mi Kyung; Kim, Hye Soon; Ryu, Seong Yeol; Kwon, Ki Young; Park, Keun Gyu
- Department
- Dept. of Internal Medicine (내과학)
- Journal Title
- 대한내과학회지
- Issued Date
- 2010
- Volume
- 78
- Issue
- 4
- Abstract
- Sunitinib is a tyrosine-kinase inhibitor used to treat metastatic renal cell carcinoma and imatinib-resistant gastrointestinal stromal
tumors. Hypothyroidism is a common side effect of sunitinib therapy. Nevertheless, overt thyrotoxicosis induced by destructive
thyroiditis after sunitinib treatment is very rare. Here, we report a patient with overt thyrotoxicosis related to sunitinib therapy.
(Korean J Med 78:503-506, 2010)
Key Words: Sunitinib; Thyrotoxicosis
Sunitinib은 콩팥세포암종이나 위장관 기질성 종양 치료에
사용되는 약제로 갑상선기능저하증이 흔한 부작용 중의 하
나이다. 본 증례는 sunitinib 사용 1주 후 발생한 갑상선염에
의한 중증의 갑상선중독증 환자를 경험하였기에 보고하고자
한다.
중심 단어: Sunitinib; 갑상선중독증
- Alternative Title
- A case of thyrotoxicosis after sunitinib treatment
- Publisher
- School of Medicine
- Citation
- 이호영 et al. (2010). Sunitinib 치료 이후 발생한 갑상선중독증 1예. 대한내과학회지, 78(4), 503–506.
- Type
- Article
- ISSN
- 1738-9364
- Appears in Collections:
- 1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
- 파일 목록
-
-
Download
oak-bbb-00656.pdf
기타 데이터 / 514.23 kB / Adobe PDF
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.